Literature DB >> 8400824

Purification and properties of the alpha-3/4-L-fucosyltransferase released into the culture medium during the growth of the human A431 epidermoid carcinoma cell line.

P H Johnson1, A S Donald, W M Watkins.   

Abstract

A soluble alpha-3/4-fucosyltransferase secreted into the growth medium of the human A431 epidermoid carcinoma cell line has been purified 700,000 fold by a series of steps involving chromatography on Phenyl Sepharose 4B, CM-Sephadex C-50 and GDP-hexanolamine Sepharose 4B. The untreated spent culture medium transferred almost ten times more fucose to the subterminal N-acetylglucosamine residue in the Type 1 (Gal beta 1-3GlcNAc) disaccharide than to the subterminal sugar in the Type 2 (Gal beta 1-4GlcNAc) disaccharide; the relative activity with these two substrates remained virtually unchanged throughout the purification procedure. At no stage was any alpha-3-fucosyltransferase species acting solely on N-acetylglucosamine residues in Type 2 chains separated from the bulk of the alpha-3/4-fucosyltransferase activity. The purified enzyme preparation showed insignificant activity with glycoprotein substrates having N-linked oligosaccharide chains with terminal Type 2 sequences but transferred fucose to a mucin-type glycoprotein with O-linked oligosaccharide chains with terminal Type 1 structures. Lactose was a poor substrate but the activity of the enzyme was influenced by the presence of substituents on the terminal beta-galactosyl residue and 2'-fucosyllactose was almost as good an acceptor as the Type 1 disaccharide. The properties of the purified enzyme with regard to specificity, divalent cation requirements, pH optimum, and M(r), closely resembled those of the Lewis-blood-group gene associated alpha-3/4-fucosyltransferase isolated from human milk.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400824     DOI: 10.1007/bf00737712

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  28 in total

1.  Two serologically active trisaccharides isolated from human blood-group A substance.

Authors:  I A CHEESE; W T MORGAN
Journal:  Nature       Date:  1961-07-08       Impact factor: 49.962

2.  Possible genetical pathways for the biosynthesis of blood group mucopolysaccharides.

Authors:  W M WATKINS; W T MORGAN
Journal:  Vox Sang       Date:  1959-04       Impact factor: 2.144

3.  Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin.

Authors:  G Spik; B Bayard; B Fournet; G Strecker; S Bouquelet; J Montreuil
Journal:  FEBS Lett       Date:  1975-02-15       Impact factor: 4.124

4.  Detection of sugars on paper chromatograms.

Authors:  W E TREVELYAN; D P PROCTER; J S HARRISON
Journal:  Nature       Date:  1950-09-09       Impact factor: 49.962

5.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

6.  Structural studies on the carbohydrate portion of fetuin.

Authors:  B Nilsson; N E Nordén; S Svensson
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

7.  The GDP-fucose:N-acetylglucosaminide 3-alpha-L-fucosyltransferases of LEC11 and LEC12 Chinese hamster ovary mutants exhibit novel specificities for glycolipid substrates.

Authors:  D R Howard; M Fukuda; M N Fukuda; P Stanley
Journal:  J Biol Chem       Date:  1987-12-15       Impact factor: 5.157

8.  Reassessment of the acceptor specificity and general properties of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase purified from human milk.

Authors:  P H Johnson; A S Donald; J Feeney; W M Watkins
Journal:  Glycoconj J       Date:  1992-10       Impact factor: 2.916

Review 9.  Genetics of ABO, H, Lewis, X and related antigens.

Authors:  R Oriol; J Le Pendu; R Mollicone
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

10.  Blood group-active carbohydrate chains on the receptor for epidermal growth factor of A431 cells.

Authors:  R A Childs; M Gregoriou; P Scudder; S J Thorpe; A R Rees; T Feizi
Journal:  EMBO J       Date:  1984-10       Impact factor: 11.598

View more
  3 in total

1.  Purification, properties and possible gene assignment of an alpha 1,3-fucosyltransferase expressed in human liver.

Authors:  P H Johnson; A S Donald; J L Clarke; W M Watkins
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

2.  Unravelling the biochemical basis of blood group ABO and Lewis antigenic specificity.

Authors:  W T Morgan; W M Watkins
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

3.  Expression and characterization of recombinant human alpha-3/4-fucosyltransferase III from Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) cells using the baculovirus expression system.

Authors:  V A Morais; J Serpa; A S Palma; T Costa; L Maranga; J Costa
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.